Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Pepper

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|January 11, 2013
Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activitiesHao Shao, Shenhua Shi, Shiliang Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemiaPietro Bulian, Tait D Shanafelt, Chris Fegan, et al.
Blood|January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic targetSaman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.
Cancers|March 25, 2022
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple MyelomaThomas A Burley, Emma Kennedy, Georgia Broad, et al.
Blood|June 3, 2016
Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migrationMarta Pasikowska, Elisabeth Walsby, Benedetta Apollonio, et al.
International Journal of Nanomedicine|October 29, 2020
Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia CellsSuliman A Alsagaby, Rajendran Vijayakumar, Mariappan Premanathan, et al.
British Journal of Haematology|July 4, 2014
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage diseaseThet Thet Lin, Kevin Norris, Nicole H Heppel, et al.
Journal of Medicinal Chemistry|March 22, 2013
GC-targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse modelsKhondaker M Rahman, Paul J M Jackson, Colin H James, et al.
Leukemia Research|November 25, 2010
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLLAneela Majid, Thet Thet Lin, Giles Best, et al.
Leukemia|June 20, 2021
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapiesAndrea G S Pepper, Antonella Zucchetto, Kevin Norris, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|January 11, 2013
Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activitiesHao Shao, Shenhua Shi, Shiliang Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemiaPietro Bulian, Tait D Shanafelt, Chris Fegan, et al.
Blood|January 30, 2008
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic targetSaman Hewamana, Suhair Alghazal, Thet Thet Lin, et al.
Cancers|March 25, 2022
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple MyelomaThomas A Burley, Emma Kennedy, Georgia Broad, et al.
Blood|June 3, 2016
Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migrationMarta Pasikowska, Elisabeth Walsby, Benedetta Apollonio, et al.
International Journal of Nanomedicine|October 29, 2020
Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia CellsSuliman A Alsagaby, Rajendran Vijayakumar, Mariappan Premanathan, et al.
British Journal of Haematology|July 4, 2014
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage diseaseThet Thet Lin, Kevin Norris, Nicole H Heppel, et al.
Journal of Medicinal Chemistry|March 22, 2013
GC-targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse modelsKhondaker M Rahman, Paul J M Jackson, Colin H James, et al.
Leukemia Research|November 25, 2010
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLLAneela Majid, Thet Thet Lin, Giles Best, et al.
Leukemia|June 20, 2021
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapiesAndrea G S Pepper, Antonella Zucchetto, Kevin Norris, et al.
Pageof 12